Michael Lund

27 papers receiving 694 citations

Michael Lund's Hit Papers

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial 2021 · 215 citations
2150+1+3Years since publication50100150200

Peers

Michael Lund
Comparison fields: 5 of 72
  • Endocrinology, Diabetes and Metabolism 321
  • Pharmacology 235
  • Physiology 358
  • Complementary and alternative medicine 72
  • Endocrine and Autonomic Systems 55
Replace J. Ybarra with:
J. Ybarra Spain
Charlotte Janus Denmark
A. A. Connacher United Kingdom
E. Schvarcz Sweden
P. Bj�rntorp Sweden
J Gautier France
Christine M. Marchetti United States
F Ducros Canada
Naji Al‐Zaid Kuwait
Antônio Calixto Brazil
Michael Lund relative to J. Ybarra Spain J. Ybarra's profile →
Citations per field
00.5×8.9×
J. Ybarra · 1×
Citations per year

Countries citing papers authored by Michael Lund

Since Specialization
Citations

This map shows the geographic impact of Michael Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lund more than expected).

Fields of papers citing papers by Michael Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lund. The network helps show where Michael Lund may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Lund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Lund Line = papers co-authored together Michael Lund links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial
Hit paper breakdown →
2021215
2 2020142
3 201771
4 201543
5 201629
6 201528
7 201921
8 201519
9 201818
10 201215
11 201312
12 201712
13 201512
14 201510
15 201410
16 201310
17 20238
18 20166
19 20215
20 20244

About Michael Lund

Michael Lund is a scholar working on Physiology, Surgery, Endocrinology, Diabetes and Metabolism, Pharmacology and Molecular Biology, having authored 27 papers that have together received 702 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (9 papers), Bariatric Surgery and Outcomes (8 papers), Diet and metabolism studies (8 papers), Adipose Tissue and Metabolism (7 papers), Pharmacology and Obesity Treatment (5 papers), Metabolism, Diabetes, and Cancer (3 papers), Cardiovascular and exercise physiology (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (321 citations), Pharmacology (235 citations), Physiology (358 citations), Complementary and alternative medicine (72 citations) and Endocrine and Autonomic Systems (55 citations). Michael Lund has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Domenica Rubino, Flemming Dela, Jørn Wulff Helge, Altynai Satylganova, Martin Kankam, David C.W. Lau, Jena Shaw Tronieri, Thomas A. Wadden, Pernille Auerbach and Danny Sugimoto. Their work appears in journals such as Obesity, The Journal of Physiology, Acta Physiologica, Surgery for Obesity and Related Diseases and European Journal of Sport Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact